Biotech

Compumedics Limited (ASX:CMP) Chairman's Address to Shareholders

🕔10/29/2015 2:38:33 PM

Compumedics Limited (ASX:CMP) is a leading global, innovative developer and manufacturer of medical devices.

Read Full Article

Living Cell Technologies Ltd (ASX:LCT) Data Shows NTCELL Treatment Has Stopped the Progression of Parkinsons

🕔10/27/2015 3:56:18 PM

The four patients who took part in Living Cell Technologies Limited's (ASX:LCT) (OTCMKTS:LVCLY) Phase I/IIa clinical study of NTCELL(R) for Parkinson's disease have all reached the milestone of 42 weeks post-implant. All four patients remain well, and there are no safety concerns.

Read Full Article

Regeneus Ltd (ASX:RGS) First Patient Safely Treated in Cancer Vaccine Trial

🕔10/27/2015 9:59:25 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the first patient has been enrolled and safely treated in the first clinical trial of RGSH4K, the company's autologous tumour vaccine product for the treatment of solid tumours.

Read Full Article

Compumedics Limited (ASX:CMP) Initiating Research Report

🕔10/26/2015 9:21:40 AM

Compumedics Limited (ASX:CMP) is pleased to announce the release of an initiating research report by PAC partners.

Read Full Article

Erin Resources Ltd (ASX:ERI) (MGC Pharmaceuticals) CBD Skin Care Formula Completes Phase 1 Testing - Excellent Results

🕔10/21/2015 10:56:08 AM

Erin Resources Ltd (ASX:ERI) is pleased to provide investors an update on the development of MGC Pharmaceuticals' (MGC) new CBD based skin care formula for the effective relief for Psoriatic skin.

Read Full Article

Regeneus Ltd (ASX:RGS) Annual Report 2015 to Shareholders

🕔10/19/2015 10:16:33 AM

Regeneus Ltd (ASX:RGS) are pleased to provide the Company's Annual Report for 2015 to shareholders.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives R&D Tax Incentive Refund of $3.4 Million

🕔10/13/2015 10:01:17 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today reported that it has received $3.4m from the Australian Government's Research and Development Tax Incentive Program for activities conducted during the 2015 financial year.

Read Full Article